Ahmed Hegazy (pharmacist)

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) The verifiability of the claims made in this article is disputed. Please help improve this article by verifying its references and removing any that are not reliable or do not support the article. Relevant discussion may be found on the talk page. (June 2024) (Learn how and when to remove this message) This article needs more reliable medical references for verification or relies too heavily on primary sources. Please review the contents of the article and add the appropriate references if you can. Unsourced or poorly sourced material may be challenged and removed. Find sources: "Ahmed Hegazy" pharmacist – news · newspapers · books · scholar · JSTOR (June 2024) This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. Please help improve it by replacing them with more appropriate citations to reliable, independent, third-party sources. (June 2024) (Learn how and when to remove this message) (Learn how and when to remove this message)

Ahmed Hegazy (also: Hegasy; Arabic أحمد حجازي, Aḥmad Ḥiǧāzī, born October 24, 1939, in Cairo; died February 5, 2021, in Leverkusen) was an Egyptian-German pharmacist. He conducted research in the Pharmaceutical Technology Department of Bayer from 1966 to 1999, during which time he invented a new galenic formulation for the active components nifedipine and nimodipine.^{[1][medical citation needed]} By blocking calcium channels, the substance has a relaxing effect on vascular muscles and is therefore used for the treatment of hypertension.^{[medical citation needed]} In 1991, Hegazy received the Otto Bayer Medal for the solubilization of poorly soluble ingredients such as nimodipine.^{[medical citation needed]} His galenic invention is still the basis for many modern formulations at Bayer AG (A. Ohm).^{[medical citation needed]}